Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Beck

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Pathology. Clinical Research|January 29, 2024
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitorsMichael Menzel, Martina Kirchner, Klaus Kluck, et al.
European Journal of Pediatrics|March 1, 2026
Shorter versus longer antibiotic therapy for children with acute otitis media: A systematic reviewAlexander Benkendorff, Sibylle Puntscher, Magdalena Flatscher-Thöni, et al.
Deutsches Arzteblatt International|January 23, 2026
Shorter Versus Longer Antibiotic Treatment in Children With Community-Acquired Pneumonia: A Systematic Review With Meta-AnalysesAlexander Benkendorff, Sibylle Puntscher, Magdalena Flatscher-Thöni, et al.
The Journal of Molecular Diagnostics : JMD|December 14, 2024
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test: TruSight Oncology 500 HTMarkus Ball, Eva Romanovsky, Fabian Schnecko, et al.
British Journal of Cancer|April 7, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costingChristian Altbürger, Michael Menzel, Susanne Beck, et al.
British Journal of Haematology|March 13, 2020
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group modelRoman Hájek, Viera Sandecka, Ivan Špička, et al.
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Neuro-Oncology|January 5, 2025
Genome-wide CRISPR-Cas9 screens identify BCL family members as modulators of response to regorafenib in experimental gliomaLara Annina Haeusser, Hannes Becker, Laurence Kuhlburger, et al.
British Journal of Cancer|July 23, 2022
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingOlaf Neumann, Timothy C Burn, Michael Allgäuer, et al.
International Journal of Molecular Sciences|June 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income CountriesAnja Seckinger, Hans Salwender, Hans Martin, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Pathology. Clinical Research|January 29, 2024
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR-mutated lung cancer treated with the first-/second-generation tyrosine kinase inhibitorsMichael Menzel, Martina Kirchner, Klaus Kluck, et al.
European Journal of Pediatrics|March 1, 2026
Shorter versus longer antibiotic therapy for children with acute otitis media: A systematic reviewAlexander Benkendorff, Sibylle Puntscher, Magdalena Flatscher-Thöni, et al.
Deutsches Arzteblatt International|January 23, 2026
Shorter Versus Longer Antibiotic Treatment in Children With Community-Acquired Pneumonia: A Systematic Review With Meta-AnalysesAlexander Benkendorff, Sibylle Puntscher, Magdalena Flatscher-Thöni, et al.
The Journal of Molecular Diagnostics : JMD|December 14, 2024
Clinical Implementation of a High-Throughput Automated Comprehensive Genomic Profiling Test: TruSight Oncology 500 HTMarkus Ball, Eva Romanovsky, Fabian Schnecko, et al.
British Journal of Cancer|April 7, 2026
Implementing whole genome and transcriptome sequencing for cancer patients in routine healthcare: a comprehensive guide to costingChristian Altbürger, Michael Menzel, Susanne Beck, et al.
British Journal of Haematology|March 13, 2020
Identification of patients with smouldering multiple myeloma at ultra-high risk of progression using serum parameters: the Czech Myeloma Group modelRoman Hájek, Viera Sandecka, Ivan Špička, et al.
Frontiers in Immunology|November 30, 2023
RNA-sequencing based first choice of treatment and determination of risk in multiple myelomaMartina Emde-Rajaratnam, Susanne Beck, Vladimir Benes, et al.
Neuro-Oncology|January 5, 2025
Genome-wide CRISPR-Cas9 screens identify BCL family members as modulators of response to regorafenib in experimental gliomaLara Annina Haeusser, Hannes Becker, Laurence Kuhlburger, et al.
British Journal of Cancer|July 23, 2022
Genomic architecture of FGFR2 fusions in cholangiocarcinoma and its implication for molecular testingOlaf Neumann, Timothy C Burn, Michael Allgäuer, et al.
International Journal of Molecular Sciences|June 27, 2024
Molecular Long-Term Analysis of the GMMG-HD4 Trial in Multiple Myeloma-Patterns of Association of Chromosomal Aberrations with Response and Proliferation Determining Survival in Selecting Treatments in View of Limited Resources in Low- and Middle-Income CountriesAnja Seckinger, Hans Salwender, Hans Martin, et al.
Pageof 5